Recombinant Pseudomonas fluorescens Undecaprenyl-diphosphatase 2 (uppP2)

What is Undecaprenyl-diphosphatase 2 (uppP2) and what is its role in Pseudomonas fluorescens?

Undecaprenyl-diphosphatase 2 (uppP2) is an enzyme that catalyzes the conversion of undecaprenyl diphosphate (UPP) to undecaprenyl phosphate (UP). In the bacterial cell wall synthesis pathway, this conversion is a critical step that follows the formation of UPP by undecaprenyl diphosphate synthase (UPPS) . In Pseudomonas fluorescens, this enzyme plays a crucial role in cell wall biogenesis, which is essential for bacterial survival and growth. The enzyme is particularly significant as it represents a potential target for antimicrobial compounds since this pathway is not present in humans .

What are the key structural features of uppP2 that influence its function?

The structure of uppP2 includes a hydrophobic interior pocket within its ligand-binding domain (LBD), similar to other bacterial proteins like PhlF and PhlH in P. fluorescens . These binding pockets are typically surrounded by alpha helices and contain conserved aromatic residues (such as phenylalanine, tyrosine, and tryptophan) that facilitate binding of substrates through π–π stacking interactions . These structural features are critical for the enzyme's specificity and catalytic efficiency. The hydrophobic nature of the binding pocket accommodates the lipid-like structure of the undecaprenyl diphosphate substrate.

What are the recommended protocols for purifying recombinant uppP2 with optimal enzymatic activity?

Purification of recombinant uppP2 with retained enzymatic activity requires careful consideration of expression systems and purification conditions. The following protocol outline is recommended based on successful approaches with similar enzymes:

• Expression system selection: While E. coli systems offer high yield, P. fluorescens-based expression systems may provide better protein folding for challenging targets .

• Cell lysis and initial purification:

  • Buffer composition: 50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 10% glycerol, and 1 mM DTT

  • Add protease inhibitors to prevent degradation

  • Consider membrane protein extraction techniques if uppP2 shows membrane association

• Chromatography sequence:

  • Immobilized metal affinity chromatography (IMAC) for His-tagged constructs

  • Ion exchange chromatography to remove contaminants

  • Size exclusion chromatography as a final polishing step

• Activity preservation: Include stabilizing agents such as glycerol (10-20%) and reducing agents (1-5 mM DTT or β-mercaptoethanol) in storage buffers to maintain enzymatic activity .

• Quality control: Verify purity by SDS-PAGE and assess activity using phosphatase assays with synthetic substrates that mimic undecaprenyl diphosphate.

How can genetic modification techniques be optimized for creating P. fluorescens uppP2 mutants?

Creation of P. fluorescens uppP2 mutants can be achieved through a two-step homologous recombination method similar to that used for other P. fluorescens genes . The protocol involves:

• Design of deletion constructs:

  • Amplify flanking sequences (~1 kb) of the uppP2 gene using PCR

  • Clone these fragments into a suicide vector such as pK18mobsacB-Km

• Conjugation and selection:

  • Conjugate the construct into P. fluorescens strains using E. coli S17-1 as a donor strain

  • Plate on appropriate media (such as King's B agar) with selection antibiotics

  • Select for single crossover events

• Counter-selection:

  • Apply sucrose stress (typically 10-15% sucrose) to select for second homologous recombination events

  • Screen resulting colonies for the desired deletion

• Verification:

  • Confirm deletion mutants by PCR amplification and sequencing

  • Validate phenotypic changes through enzymatic assays and growth studies

• Complementation studies:

  • For functional validation, reintroduce the wild-type or modified gene on a plasmid

  • Assess restoration of phenotype to confirm gene function

What analytical methods are most reliable for measuring uppP2 enzymatic activity?

Several analytical methods can be employed to reliably measure uppP2 enzymatic activity:

Table 1: Comparative Analysis of Methods for Measuring uppP2 Activity

Researchers should select the appropriate method based on available equipment, required sensitivity, and specific experimental questions. For initial screening of mutants or inhibitors, colorimetric assays may be sufficient, while detailed kinetic studies might require more sensitive approaches like HPLC or mass spectrometry .

How does the expression of uppP2 in P. fluorescens compare with other Pseudomonas species, and what implications does this have for antimicrobial resistance?

Expression patterns of uppP2 across Pseudomonas species show significant variations that may contribute to differential antimicrobial susceptibility profiles. In P. fluorescens, uppP2 expression is regulated through complex signaling networks that involve interspecies communication molecules such as pyoluteorin (PLT) . The regulatory mechanisms are mediated by TetR family repressors similar to PhlH and PhlF, which have been shown to coordinate secondary metabolic pathways by sensing interspecies signals .

Comparative genomic analyses suggest that while the core enzymatic function of uppP2 is conserved across Pseudomonas species, regulatory elements may differ significantly. These differences potentially contribute to:

• Variable susceptibility to antibiotics targeting cell wall synthesis

• Differential adaptation to environmental stresses

• Species-specific responses to signaling molecules in mixed microbial communities

The widespread distribution of similar regulatory systems among Pseudomonas species, with conserved ligand-binding domains (LBDs), suggests a potentially conserved mechanism that could be exploited for developing broad-spectrum antimicrobials targeting this group of bacteria .

What structural modifications to uppP2 might enhance its stability while preserving catalytic activity?

Based on structural analyses of similar enzymes in P. fluorescens, several strategies can be considered for enhancing uppP2 stability while maintaining catalytic function:

• Targeted mutagenesis of non-catalytic residues:

  • Introduce disulfide bridges in regions distant from the active site

  • Replace surface-exposed hydrophobic residues with polar ones to reduce aggregation

  • Stabilize alpha-helical regions through introduction of helix-favoring residues

• Protein engineering approaches:

  • Create chimeric proteins incorporating stable domains from thermophilic organisms

  • Apply consensus design by aligning sequences from multiple species and selecting the most conserved residues

  • Use computational design tools to identify stabilizing mutations

• Expression system optimization:

  • Select expression systems that facilitate proper post-translational modifications

  • Insect cells with baculovirus or mammalian cells may provide post-translational modifications crucial for correct protein folding and activity maintenance

• Formulation strategies:

  • Identify optimal buffer compositions including stabilizing co-factors

  • Determine protective excipients that prevent denaturation during purification and storage

A systematic approach combining these strategies, followed by rigorous activity assays, would be most effective for developing stability-enhanced variants of uppP2.

How do interspecies signaling molecules affect the expression and activity of uppP2 in P. fluorescens?

Interspecies signaling molecules play a crucial role in regulating gene expression in P. fluorescens, including genes involved in cell wall synthesis such as uppP2. Recent studies have demonstrated that pyoluteorin (PLT), an antibiotic produced by some Pseudomonas strains, functions as an interspecies signal that can modulate the expression of biosynthetic gene clusters .

The regulatory mechanism appears to involve TetR family repressors that sense these signaling molecules and alter gene expression patterns accordingly. For example, PLT can bind to repressors like PhlH and PhlF, causing conformational changes that affect their DNA-binding properties . This binding can either induce dissociation from promoter regions (as seen with PhlH) or maintain the repressed state (as observed with PhlF).

The implications for uppP2 regulation are significant, as similar regulatory networks likely control its expression. This complex regulation ensures appropriate allocation of cellular resources and coordinates metabolic pathways in response to environmental cues and neighboring microbial populations .

What are the critical parameters to optimize when designing inhibition studies targeting uppP2?

When designing inhibition studies targeting uppP2, researchers should consider the following critical parameters:

• Inhibitor selection and design:

  • Focus on compounds that target the unique structural features of bacterial UPPPs

  • Consider benzoic acids and phenylphosphonic acids, which have shown promise as inhibitors of related enzymes

  • Design inhibitors based on structural understanding of the binding pocket

• Assay development:

  • Establish reliable, reproducible assays with appropriate controls

  • Determine optimal enzyme concentration to observe inhibition effects

  • Consider substrate concentration relative to Km values

• Specificity testing:

  • Test against human phosphatases to ensure selectivity

  • Evaluate activity against other bacterial species to determine spectrum

• Experimental conditions:

  • Optimize buffer composition, pH, and ionic strength

  • Determine appropriate incubation times and temperatures

  • Account for potential inhibitor solubility issues

• Data analysis:

  • Calculate IC50 values using appropriate curve-fitting models

  • Determine inhibition mechanisms (competitive, non-competitive, uncompetitive)

  • Correlate enzyme inhibition with bacterial growth inhibition

Table 2: Recommended Conditions for uppP2 Inhibition Studies

How can heterologous expression systems be optimized for studying P. fluorescens uppP2?

Optimization of heterologous expression systems for P. fluorescens uppP2 requires a multifaceted approach:

• Expression vector design:

  • Select appropriate promoters (constitutive vs. inducible)

  • Optimize codon usage for the host organism

  • Include fusion tags (His, GST, MBP) to facilitate purification and potentially enhance solubility

  • Consider secretion leaders for periplasmic localization to enhance disulfide bond formation and proper folding

• Host selection:

  • E. coli: High yields and rapid expression, but may lack appropriate post-translational modifications

  • Yeast: Good yields with some eukaryotic post-translational modifications

  • Insect cells: More complex post-translational modifications, potentially better folding

  • P. fluorescens itself: Native environment but potentially lower yields

• Expression conditions:

  • Temperature: Lower temperatures (16-25°C) often improve proper folding

  • Induction timing: Optimize based on growth phase

  • Media composition: Rich vs. minimal media, supplementation with cofactors

  • Induction strength: Modulate inducer concentration to balance yield and proper folding

• Scale-up considerations:

  • Implement design of experiments (DoE) approaches to identify optimal conditions

  • Transfer from 96-well scale to fermentation scale with process monitoring

  • Scout controlled growth and induction conditions

• Protein analysis techniques:

  • Implement high-throughput titer assays (SDS-CGE, BLI technologies)

  • Screen thousands of strains in parallel at 96-well scale

  • Utilize automated systems for consistent results

The Pelican Expression Technology platform, which is based on P. fluorescens, offers particular advantages for challenging proteins due to its ability to rapidly identify optimal expression strategies .

How should researchers interpret contradictory results between in vitro and in vivo studies of uppP2 inhibitors?

When facing contradictions between in vitro and in vivo studies of uppP2 inhibitors, researchers should consider multiple factors that might explain these discrepancies:

• Compound bioavailability:

  • Assess cell permeability of inhibitors

  • Consider potential efflux mechanisms

  • Evaluate compound stability in physiological conditions

• Target engagement:

  • Confirm that the inhibitor reaches the target in vivo

  • Develop target engagement assays (e.g., cellular thermal shift assays)

  • Consider differences in protein conformation or modification in cellular environments

• Off-target effects:

  • Investigate potential secondary targets

  • Perform comprehensive proteomics to identify other affected pathways

  • Consider effects on host cells/tissues in animal models

• Compensatory mechanisms:

  • Evaluate potential redundancy in enzymatic pathways

  • Consider upregulation of alternate enzymes in response to inhibition

  • Assess changes in gene expression profiles

• Experimental design considerations:

  • Re-examine dosing regimens

  • Consider pharmacokinetic/pharmacodynamic relationships

  • Evaluate model appropriateness (cell lines, animal models)

A systematic approach to resolving contradictions might include:

• Performing dose-response studies across multiple models

• Developing more physiologically relevant in vitro assays

• Using genetic approaches (e.g., CRISPR/Cas9) to validate target specificity

• Employing combination approaches to address potential compensatory mechanisms

What statistical methods are most appropriate for analyzing enzyme kinetics data for uppP2?

The analysis of enzyme kinetics data for uppP2 requires rigorous statistical approaches to ensure reliable interpretation. The following statistical methods are recommended based on the type of analysis being performed:

• Michaelis-Menten kinetics analysis:

  • Non-linear regression for fitting to Michaelis-Menten equation

  • Lineweaver-Burk, Eadie-Hofstee, or Hanes-Woolf transformations for visual analysis

  • Calculation of confidence intervals for Km and Vmax parameters

• Inhibition studies:

  • Global fitting approaches for determining inhibition mechanisms

  • Statistical comparison of different inhibition models (competitive, non-competitive, uncompetitive)

  • Analysis of variance (ANOVA) for comparing IC50 values across experimental conditions

• Time-course experiments:

  • Regression analysis for initial velocity determination

  • Time-series analysis for identifying biphasic kinetics or time-dependent inhibition

  • Bootstrap methods for robust parameter estimation

• Comparative studies across conditions or mutants:

  • Multiple comparison tests with appropriate corrections (e.g., Bonferroni, Tukey HSD)

  • Two-way ANOVA for evaluating interactions between factors

  • Power analysis to ensure sufficient sample size

• Quality control and validation:

  • Residual analysis to verify model assumptions

  • Outlier detection methods (Cook's distance, DFBETA)

  • Cross-validation techniques to assess model robustness

Table 3: Statistical Software Packages for Enzyme Kinetics Analysis

What emerging technologies might advance our understanding of uppP2 structure-function relationships?

Several cutting-edge technologies hold promise for deepening our understanding of uppP2 structure-function relationships:

• Advanced structural biology approaches:

  • Cryo-electron microscopy for visualizing membrane-associated conformations

  • Microcrystal electron diffraction for structures of challenging proteins

  • Serial femtosecond crystallography using X-ray free-electron lasers for capturing enzyme dynamics

  • Integrative structural biology combining multiple data sources (NMR, SAXS, XL-MS)

• Computational advances:

  • AlphaFold and similar AI-based structure prediction tools for modeling variants

  • Molecular dynamics simulations on longer timescales to capture conformational changes

  • Quantum mechanics/molecular mechanics (QM/MM) for detailed catalytic mechanism studies

  • Deep learning approaches to predict functional effects of mutations

• High-throughput functional genomics:

  • CRISPR-based screening for identifying genetic interactions

  • Deep mutational scanning to comprehensively map sequence-function relationships

  • Single-cell technologies to monitor heterogeneity in response to inhibitors

• Advanced spectroscopy:

  • Time-resolved spectroscopy to capture catalytic intermediates

  • Single-molecule FRET to observe conformational dynamics

  • Hydrogen-deuterium exchange mass spectrometry to map protein dynamics and interactions

• Synthetic biology approaches:

  • Creation of minimal synthetic pathways to study uppP2 in controlled contexts

  • Engineering of biosensors for real-time monitoring of enzyme activity

  • Development of orthogonal translation systems for incorporating non-canonical amino acids

These technologies, especially when used in combination, could provide unprecedented insights into the molecular mechanisms of uppP2 and facilitate the development of new inhibitors targeting this enzyme.

How might understanding of uppP2 contribute to development of novel antimicrobial strategies?

Understanding of uppP2 could significantly contribute to novel antimicrobial strategies through several mechanisms:

• Direct enzyme inhibition approaches:

  • Design of specific inhibitors targeting the uppP2 active site

  • Development of allosteric inhibitors that stabilize inactive conformations

  • Creation of covalent inhibitors that irreversibly modify catalytic residues

• Targeting regulatory networks:

  • Manipulation of TetR family repressors that regulate uppP2 expression

  • Exploitation of interspecies signaling pathways that modulate enzyme production

  • Disruption of quorum sensing mechanisms that coordinate cell wall synthesis

• Combination strategies:

  • Synergistic targeting of multiple steps in the undecaprenyl phosphate pathway

  • Development of dual-action compounds affecting both synthesis and recycling

  • Designing inhibitors that sensitize bacteria to existing antibiotics

• Host-directed therapies:

  • Modulation of host immune responses to enhance clearance of bacteria with compromised cell walls

  • Development of compounds that increase penetration of antibiotics through bacterial membranes

  • Creation of delivery systems targeting bacteria with specific cell wall compositions

• Biotechnological applications:

  • Engineering of P. fluorescens strains with modified uppP2 for production of novel antimicrobials

  • Development of whole-cell biosensors for screening environmental samples

  • Creation of synthetic bacterial communities with optimized antimicrobial production

The unique nature of the bacterial cell wall synthesis pathway, including uppP2, makes it an attractive target for antimicrobial development, as these pathways are not present in humans . This potentially allows for selective toxicity, a critical feature of effective antimicrobial agents.